DB
Healthcare & Life Sciences
Deck Bio
United Statesdeck.bio/
Deck Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About Deck Bio
Deck Bio is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Deck Bio develops multi-target T cell engager therapeutics that recognize multiple cancer-specific peptide-MHC complexes to improve immune system targeting of tumors and overcome tumor heterogeneity and resistance in solid cancers.
Explore Deck Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.